MedPageToday
MedPage Today) — SAN DIEGO — Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the bispecific T-cell engager blinatumomab (Blincyto) in addition…
Read More
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia
MedPage Today) — SAN DIEGO — Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the bispecific T-cell engager blinatumomab (Blincyto) in addition…